Application Notes & Case Studies
-
Global Pharmaceutical Company Implements Remote Clinician Ratings
8/30/2023
Uncover the secret to how this pharma company was able to implement remote clinician ratings in a multinational Alzheimer’s disease.
-
RTSM Manages Clinical IP Dispensation In Schizophrenia Study
8/30/2023
Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.
-
Global Pharma Enables Remote Sample Collection With eCOA Solution
8/30/2023
Unearth how a worldwide pharmaceutical company was able to facilitate the remote collection of stool specimens from patients at their residences as needed for research on infectious diseases.
-
Rating Services Improve Signal Detection In Depressive Disorder Trials
8/29/2023
Delve into a comprehensive understanding of several impactful contributions made during five MDD clinical trials and their outcomes.
-
Decentralized Trials For Duchenne Muscular Dystrophy
8/24/2023
Partnering with a global biotech, see how MRN was able to conduct 180+ monthly home visits to sustain trials for rare disease genetic medicine in vulnerable pediatric patients during COVID-19.
-
Ground-Breaking AD Treatment Gains Accelerated FDA Approval
8/17/2023
Discover how robust and standardized imaging and cardiac safety data helped to speed up the FDA approval process in a complex Alzheimer’s Disease study.
-
MBC Alliance Boosts Engagement And Data With Research Registry
8/16/2023
Unearth how a patient experience registry was able to provide bi-directional benefits to the Metastatic Breast Cancer Alliance's research efforts and its patient population.
-
Essity Uses eConsent To Optimize Enrollment
8/15/2023
See how a global hygiene and health company was able to deploy virtual methods through a strategic partnership to recruit and retain participants, streamline consent, and analyze patient data.
-
Solutions Support Endpoint Reliability In Pediatric Rare Disease Trial
8/15/2023
Dive into this case study where a pharmaceutical sponsor running a trial for a new treatment for a rare pediatric disease employed solutions and services dedicated to enhancing endpoint reliability.
-
Endpoint Reliability And eCOA Solutions Facilitate CNS Trial Success
8/15/2023
A Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.